blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0651993

EP0651993 - PERCUTANEOUSLY ADMINISTRABLE BASE COMPOSITION AND DRUG COMPOSITION PREPARED THEREFROM [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  15.08.2003
Database last updated on 19.10.2024
Most recent event   Tooltip15.08.2003No opposition filed within time limitpublished on 01.10.2003  [2003/40]
Applicant(s)For all designated states
Hisamitsu Pharmaceutical Co., Inc.
408, Tashirodaikanmachi
Tosu-shi, Saga 841 / JP
[N/P]
Former [2002/41]For all designated states
HISAMITSU PHARMACEUTICAL CO., INC.
408, Tashirodaikanmachi
Tosu-shi Saga 841 / JP
Former [1995/19]For all designated states
HISAMITSU PHARMACEUTICAL CO. INC.
408, Tashirodaikanmachi
Tosu-shi Saga 841 / JP
Inventor(s)01 / HIGO, Naruhito, Tsukuba Institute of Hisamitsu
Pharmaceutical Co. Inc., 25-11, Kannondai 1-chome
Tsukuba-shi, Ibaragi 305 / JP
02 / KOJIMA, Yukio, Tsukuba Institute of Hisamitsu
Pharmaceutical Co. Inc., 25-11, Kannondai 1-chome
Tsukuba-shi, Ibaragi 305 / JP
03 / KOMORI, Ken-ichi, Tsukuba Institute of Hisamitsu
Pharmaceutical Co. Inc., 25-11, Kannondai 1-chome
Tsukuba-shi, Ibaragi 305 / JP
[1995/19]
Representative(s)Webber, Philip Michael
Dehns
St Bride's House
10 Salisbury Square
London
EC4Y 8JD / GB
[N/P]
Former [2002/27]Webber, Philip Michael
Frank B. Dehn & Co., 179 Queen Victoria Street
London EC4V 4EL / GB
Former [1996/33]Pett, Christopher Phineas
Frank B. Dehn & Co., European Patent Attorneys, 179 Queen Victoria Street
London EC4V 4EL / GB
Former [1995/19]Matthews, Derek Peter, et al
Frank B. Dehn & Co. Imperial House 15-19 Kingsway
London WC2B 6UZ / GB
Application number, filing date93916216.023.07.1993
[1995/19]
WO1993JP01034
Priority number, dateJP1992021836923.07.1992         Original published format: JP 21836992
JP1992022922604.08.1992         Original published format: JP 22922692
[1995/19]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9402119
Date:03.02.1994
Language:EN
[1994/04]
Type: A1 Application with search report 
No.:EP0651993
Date:10.05.1995
Language:EN
The application published by WIPO in one of the EPO official languages on 03.02.1994 takes the place of the publication of the European patent application.
[1995/19]
Type: B1 Patent specification 
No.:EP0651993
Date:09.10.2002
Language:EN
[2002/41]
Search report(s)International search report - published on:JP03.02.1994
(Supplementary) European search report - dispatched on:EP06.01.1997
ClassificationIPC:A61K9/00, A61K47/10, A61K47/26, A61K47/14
[1997/04]
CPC:
A61K9/0014 (EP,US); A61K47/10 (EP,US); A61P11/10 (EP);
A61P11/14 (EP); A61P21/02 (EP); A61P23/00 (EP);
A61K47/14 (EP,US); A61K47/26 (EP,US); A61K47/38 (EP,US) (-)
Former IPC [1995/19]A61K9/00
Designated contracting statesAT,   BE,   CH,   DE,   ES,   FR,   GB,   IT,   LI,   NL,   SE [1995/19]
TitleGerman:PERKUTAN VERABREICHBARE BASISZUSAMMENSETZUNG UND DARAUS HERGESTELLTE ZUSAMMENSETZUNG[2001/48]
English:PERCUTANEOUSLY ADMINISTRABLE BASE COMPOSITION AND DRUG COMPOSITION PREPARED THEREFROM[1995/19]
French:COMPOSITION DE BASE POUR ADMINISTRATION PERCUTANEE ET COMPOSITION DE MEDICAMENT DERIVEE DE CELLE-CI[2001/48]
Former [1995/19]PERKUTAN VERABREICHBARE BASISZUSAMMENSETZUNG UND DAVON HERGESTELLTE ZUSAMMENSETZUNG
Former [1995/19]COMPOSITION DE BASE ADMINISTRABLE PAR INJECTION PERCUTANEE ET COMPOSITION DE MEDICAMENT DERIVEE
Entry into regional phase17.02.1995Translation filed 
17.02.1995National basic fee paid 
17.02.1995Search fee paid 
17.02.1995Designation fee(s) paid 
17.02.1995Examination fee paid 
Examination procedure22.11.1993Request for preliminary examination filed
International Preliminary Examining Authority: JP
17.02.1995Examination requested  [1995/19]
29.11.1999Despatch of a communication from the examining division (Time limit: M06)
08.06.2000Reply to a communication from the examining division
25.08.2000Despatch of a communication from the examining division (Time limit: M06)
12.04.2001Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
21.06.2001Reply to a communication from the examining division
30.11.2001Despatch of communication of intention to grant (Approval: No)
09.04.2002Despatch of communication of intention to grant (Approval: later approval)
25.04.2002Communication of intention to grant the patent
05.08.2002Fee for grant paid
05.08.2002Fee for publishing/printing paid
Opposition(s)10.07.2003No opposition filed within time limit [2003/40]
Request for further processing for:21.06.2001Request for further processing filed
21.06.2001Full payment received (date of receipt of payment)
Request granted
05.07.2001Decision despatched
Fees paidRenewal fee
25.07.1995Renewal fee patent year 03
22.07.1996Renewal fee patent year 04
28.07.1997Renewal fee patent year 05
27.07.1998Renewal fee patent year 06
26.07.1999Renewal fee patent year 07
26.07.2000Renewal fee patent year 08
25.07.2001Renewal fee patent year 09
24.07.2002Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]US4719239  (MULLER BERND W W [DE], et al);
 [A]WO9207590  (ALZA CORP [US]) [A] 6 * claims 8,9 *
International search[XY]JPH02115131  (THERATECH INC [US])
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.